Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
23-3
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Index of Authors
Author #29769
advertisement
Sun XH
23
Showing records 1 to 23 |
Display all abstracts from
Sun XH
106854
Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Chen XL
International Journal of Ophthalmology
2023; 16: 108-114
106665
EphA4/ephrinA3 reverse signaling induced Müller cell gliosis and production of pro-inflammatory cytokines in experimental glaucoma
Xu LJ
Brain Research
2023; 1801: 148204
106290
Strengthening the clinical research of minimally invasive glaucoma surgery
Chen JY
Chinese Journal of Ophthalmology
2022; 58: 863-867
106595
The study of the correlation between age and the pathogenic factors of primary glaucoma: a review
Tan C
Chinese Journal of Ophthalmology
2022; 58: 1106-1110
106665
EphA4/ephrinA3 reverse signaling induced Müller cell gliosis and production of pro-inflammatory cytokines in experimental glaucoma
Wang HN
Brain Research
2023; 1801: 148204
106290
Strengthening the clinical research of minimally invasive glaucoma surgery
Sun XH
Chinese Journal of Ophthalmology
2022; 58: 863-867
106854
Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Fu YJ
International Journal of Ophthalmology
2023; 16: 108-114
106595
The study of the correlation between age and the pathogenic factors of primary glaucoma: a review
Hou Y
Chinese Journal of Ophthalmology
2022; 58: 1106-1110
106665
EphA4/ephrinA3 reverse signaling induced Müller cell gliosis and production of pro-inflammatory cytokines in experimental glaucoma
Zhou H
Brain Research
2023; 1801: 148204
106595
The study of the correlation between age and the pathogenic factors of primary glaucoma: a review
Qiao YS
Chinese Journal of Ophthalmology
2022; 58: 1106-1110
106854
Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Qu B; Wang YW
International Journal of Ophthalmology
2023; 16: 108-114
106595
The study of the correlation between age and the pathogenic factors of primary glaucoma: a review
Chen JY
Chinese Journal of Ophthalmology
2022; 58: 1106-1110
106665
EphA4/ephrinA3 reverse signaling induced Müller cell gliosis and production of pro-inflammatory cytokines in experimental glaucoma
Li SY; Li F
Brain Research
2023; 1801: 148204
106595
The study of the correlation between age and the pathogenic factors of primary glaucoma: a review
Sun XH
Chinese Journal of Ophthalmology
2022; 58: 1106-1110
106854
Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Tang X
International Journal of Ophthalmology
2023; 16: 108-114
106665
EphA4/ephrinA3 reverse signaling induced Müller cell gliosis and production of pro-inflammatory cytokines in experimental glaucoma
Miao Y
Brain Research
2023; 1801: 148204
106854
Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Wang YH; Zhou GY
International Journal of Ophthalmology
2023; 16: 108-114
106665
EphA4/ephrinA3 reverse signaling induced Müller cell gliosis and production of pro-inflammatory cytokines in experimental glaucoma
Lei B
Brain Research
2023; 1801: 148204
106854
Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Lin MK
International Journal of Ophthalmology
2023; 16: 108-114
106665
EphA4/ephrinA3 reverse signaling induced Müller cell gliosis and production of pro-inflammatory cytokines in experimental glaucoma
Sun XH; Gao F
Brain Research
2023; 1801: 148204
106854
Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Shen JY
International Journal of Ophthalmology
2023; 16: 108-114
106665
EphA4/ephrinA3 reverse signaling induced Müller cell gliosis and production of pro-inflammatory cytokines in experimental glaucoma
Wang Z
Brain Research
2023; 1801: 148204
106854
Safety profile of 0.0015% tafluprost eye drops in China: a post-marketing observational study
Yao J; Li SY; Wu MQ; Peng HZ; Lai MY; Wu RY; Zhang YN; Li Y; Wu XJ; Zhang MC; Guo SP; Sun XH
International Journal of Ophthalmology
2023; 16: 108-114
Issue
23-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement